Identification and in vivoefficacy assessment of approved orally bioavailable human host protein-targeting drugs with broad anti-influenza a activity
10.3389/fimmu.2019.01097
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
Frontiers Media S.A.
2021
|
| Subjects: | |
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/210832 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-210832 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-2108322024-04-02T07:44:09Z Identification and in vivoefficacy assessment of approved orally bioavailable human host protein-targeting drugs with broad anti-influenza a activity Enkirch, T. Sauber, S. Anderson, D.E. Gan, E.S. Kenanov, D. Maurer-Stroh, S. Von Messling, V. BIOLOGICAL SCIENCES Animal models Antiviral (H1N1 and H3N2) activity Drug repurposing Host protein-targeting drugs Influenza A virus 10.3389/fimmu.2019.01097 Frontiers in Immunology 10 JUN 1097 2021-12-16T07:52:52Z 2021-12-16T07:52:52Z 2019 Article Enkirch, T., Sauber, S., Anderson, D.E., Gan, E.S., Kenanov, D., Maurer-Stroh, S., Von Messling, V. (2019). Identification and in vivoefficacy assessment of approved orally bioavailable human host protein-targeting drugs with broad anti-influenza a activity. Frontiers in Immunology 10 (JUN) : 1097. ScholarBank@NUS Repository. https://doi.org/10.3389/fimmu.2019.01097 16643224 https://scholarbank.nus.edu.sg/handle/10635/210832 Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/ Frontiers Media S.A. Scopus OA2019 |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| topic |
Animal models Antiviral (H1N1 and H3N2) activity Drug repurposing Host protein-targeting drugs Influenza A virus |
| spellingShingle |
Animal models Antiviral (H1N1 and H3N2) activity Drug repurposing Host protein-targeting drugs Influenza A virus Enkirch, T. Sauber, S. Anderson, D.E. Gan, E.S. Kenanov, D. Maurer-Stroh, S. Von Messling, V. Identification and in vivoefficacy assessment of approved orally bioavailable human host protein-targeting drugs with broad anti-influenza a activity |
| description |
10.3389/fimmu.2019.01097 |
| author2 |
BIOLOGICAL SCIENCES |
| author_facet |
BIOLOGICAL SCIENCES Enkirch, T. Sauber, S. Anderson, D.E. Gan, E.S. Kenanov, D. Maurer-Stroh, S. Von Messling, V. |
| format |
Article |
| author |
Enkirch, T. Sauber, S. Anderson, D.E. Gan, E.S. Kenanov, D. Maurer-Stroh, S. Von Messling, V. |
| author_sort |
Enkirch, T. |
| title |
Identification and in vivoefficacy assessment of approved orally bioavailable human host protein-targeting drugs with broad anti-influenza a activity |
| title_short |
Identification and in vivoefficacy assessment of approved orally bioavailable human host protein-targeting drugs with broad anti-influenza a activity |
| title_full |
Identification and in vivoefficacy assessment of approved orally bioavailable human host protein-targeting drugs with broad anti-influenza a activity |
| title_fullStr |
Identification and in vivoefficacy assessment of approved orally bioavailable human host protein-targeting drugs with broad anti-influenza a activity |
| title_full_unstemmed |
Identification and in vivoefficacy assessment of approved orally bioavailable human host protein-targeting drugs with broad anti-influenza a activity |
| title_sort |
identification and in vivoefficacy assessment of approved orally bioavailable human host protein-targeting drugs with broad anti-influenza a activity |
| publisher |
Frontiers Media S.A. |
| publishDate |
2021 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/210832 |
| _version_ |
1795301682753568768 |